Search results
Results from the WOW.Com Content Network
Allergan: Off-label promotion of Botox, September 2010 Allergan, the manufacturer of Botox, agreed to a $600 million settlement to resolve all civil and criminal liability surrounding the promotion of Botox for treatment of chronic migraines before FDA review or approval of the drug for such use.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. [1][2][3] The company is the maker of Botox.
Pharmaceutical company Allergan (AGN) has settled the Department of Justice's criminal and civil charges that it promoted Botox for uses the Food and Drug Administration hadn't approved as safe ...
Botox may ease wrinkles, but a $600 million government fine today of its manufacturer Allergan is making clear it's not a legal remedy for headaches, pains and juvenile cerebral palsy. The Justice ...
The owner of the spa where she gave the illegal injections said she didn’t know about the activities that cost one of her former employees a registered nurse license.
Actavis Generics[1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics.
AOL Mail offers a free email service with customizable themes, tabs, and document views to enhance your inbox experience.